qz
Pfizer's experimental lung cancer drug fails to extend survival in late-stage trial

The drug, acquired in Pfizer's $43 billion purchase of Seagen, did not outlast standard chemotherapy in a 703-patient study [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years

Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]

Match Score: 104.41

Destination
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

Match Score: 96.16

Destination
FDA approves at-home pap smear alternative device for cervical cancer screening

The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]

Match Score: 91.77

venturebeat
Most enterprises can't stop stage-three AI agent threats, VentureBeat survey finds

A rogue AI agent at Meta passed every identity check and still exposed sensitive data to unauthorized employees in March. Two weeks later, Mercor, a $10 billion AI startup, confirmed a supply-chain br [...]

Match Score: 85.82

Destination
Tony Hogben, Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS) – Interview Series

Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how [...]

Match Score: 71.65

qz
GSK is acquiring lung cancer biotech Nuvalent in its biggest deal in over a decade

The all-cash deal, GSK's largest in more than a decade, gives the British drugmaker two late-stage lung cancer drugs under FDA review [...]

Match Score: 56.56

venturebeat
RAG precision tuning can quietly cut retrieval accuracy by 40%, putting agentic pipelines at risk

Enterprise teams that fine-tune their RAG embedding models for better precision may be unintentionally degrading the retrieval quality those pipelines depend on, according to new research from Redis.T [...]

Match Score: 51.34

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 47.63

Destination
Pfizer just had a big setback in its race for an Ozempic competitor

Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.Read more... [...]

Match Score: 43.80